# Atomoxetine for the Treatment of Cannabis Dependence

> **NCT00167297** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 16 (actual)

## Conditions studied

- Cannabis Dependence

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00167297
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167297, "Atomoxetine for the Treatment of Cannabis Dependence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00167297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*